Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

Biosimilars in development and approved by FDA 2019, by manufacturer

Biosimilars in development and approved by the FDA as of May 2019, by manufacturer

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

2019

Region

United States

Survey time period

as of May 2019

Supplementary notes

Includes biosimilars for hematology, inflammation and immunology, and oncology and may not be all-inclusive.
* Includes biosimilars in Preclinical, Phase 1, Phase 2, Phase 3, or submitted to FDA. Totals based on publicly available information. Additional biosimilars could be in preclinical or phase 1 development and not yet reported publicly.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Teva"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.